(Q40368192)

19 September 2017

title

Bcl-X(L) is functionally non-equivalent for the regulation of growth and survival in human ovarian cancer cells (English)

1 reference

19 September 2017

1 reference

Phillipe Dodier

1

1 reference

19 September 2017

Alain Piché

series ordinal

2

1 reference

19 September 2017

language of work or name

English

0 references

publication date

26 September 2005

1 reference

19 September 2017

1 reference

19 September 2017

volume

100

1 reference

19 September 2017

issue

2

1 reference

19 September 2017

page(s)

254-263

1 reference

Epithelial ovarian cancer: prevention, diagnosis, and treatment

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.028

Apoptosis: a link between cancer genetics and chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.028

Molecular mechanisms of "detachment-induced apoptosis--Anoikis".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.028

BCL-2 family members and the mitochondria in apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.028

The Bcl-2 protein family: arbiters of cell survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.028

Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-x but not bcl-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.028

Bcl-xL is expressed in ovarian carcinoma and modulates chemotherapy-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.028

Expression of Bcl-xL in ovarian carcinoma is associated with chemoresistance and recurrent disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.028

Acquired alkylating drug resistance of a human ovarian carcinoma cell line is unaffected by altered levels of pro- and anti-apoptotic proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.028

BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.028

Overexpression of Bcl-x(L) promotes chemotherapy resistance of mammary tumors in a syngeneic mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.028

Phenotypic knock-out of the latent membrane protein 1 of Epstein-Barr virus by an intracellular single-chain antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.028

Bcl-2 decreases cell proliferation and promotes accumulation of cells in S phase without affecting the rate of apoptosis in human ovarian carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.028

Expression of apoptosis-related proteins is an independent determinant of patient prognosis in advanced ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.028

Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.08.028

10.1016/J.YGYNO.2005.08.028

7 January 2021

Identifiers

DOI

1 reference

release_d3lrya3e7bgovf3aavj6gb5sui

19 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/d3lrya3e7bgovf3aavj6gb5sui

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference